The US Food and Drug Administration (FDA) has announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER). 

Dr. Tidmarsh earned his M.D. and Ph.D. in cancer biology from Stanford University, where he completed residency training in pediatrics. He went on to complete two subspecialty programs at Stanford, one in pediatric oncology and another in neonatology. He has over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents.  

Dr. Tidmarsh was also the founding co-director of Stanford’s Master of Translational Research and Applied Medicine (M-TRAM) program, which bridges academic research and clinical application by training students and researchers to translate scientific discoveries into real-world medical solutions.  

Dr. Tidmarsh has led the successful clinical development of seven FDA-approved drugs and served as founder and CEO of multiple bio/pharmaceutical companies focused on oncology and critical care medicine. He has also served on advisory boards across academia, government, and industry. 

Source: US Food and Drug Administration